VectorY
Experienced financial business professional with more than 20 years of biotech experience, staring his career at PWC in Utrecht, the Netherlands. André has held senior financial positions at various private and listed biotech companies including Senior VP Finance at ProQR, CFO at Amsterdam Molecular Therapeutics (now UniQure) and Director of International Finance at IsoTis. He has played an instrumental role during various corporate transactions as well as ProQR’s IPO on Nasdaq and Amsterdam Molecular Therapeutic’s and IsoTis’s IPO’s on Euronext Amsterdam. André received his MSc business economics and his RA (Dutch CPA) from the Erasmus University in Rotterdam.
This person is not in the org chart
This person is not in any offices
VectorY
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide.